Chen, RuiJun
6 papers on CoChatORCID 0000-0001-5281-4143
Most cited papers
- Verified
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine
COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms
Cited by 2,234
- Verified
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Suchard, M. A., Schuemie, M. J., Krumholz, H. M., You, S. C., Chen, R., Pratt, N., Reich, C. G., Duke, J., Madigan, D., Hripcsak, G., et al. (2019) · The Lancet
Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention
Cited by 359
- Verified
Measurement of clinical documentation burden among physicians and nurses using electronic health records: a scoping review
Moy, A. J., Schwartz, J. M., Chen, R., Sadri, S., Lucas, E., Cato, K. D., & Rossetti, S. C. (2021) · Journal of the American Medical Informatics Association
Electronic Health Records SystemsNursing Diagnosis and Documentation
Cited by 284
- Verified
Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers
Chen, R., Desai, N. R., Ross, J. S., Zhang, W., Chau, K. H., Wayda, B., Murugiah, K., Lu, D. Y., Mittal, A., & Krumholz, H. M. (2016) · BMJ
Pharmaceutical industry and healthcareAcademic Publishing and Open Access
Cited by 227
- Verified
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
Chen, R., Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., Pratt, N., Reich, C. G., Madigan, D., You, S. C., et al. (2021) · Hypertension
Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies
Cited by 190
- Verified
Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
Khera, R., Schuemie, M. J., Lu, Y., Ostropolets, A., Chen, R., Hripcsak, G., Ryan, P. B., Krumholz, H. M., & Suchard, M. A. (2022) · BMJ Open
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free